0.1668
price down icon0.89%   -0.0015
 
loading

Finanzdaten der Bioatla Inc-Aktie (BCAB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - 11.00
Operating Expenses
26.05%
13.79
18.65 17.61 16.24 22.27
Operating Income/Loss
26.05%
-13.79
-18.65 -17.61 -16.24 -11.27
Income/Loss From Continuing Operations Before Tax
15.68%
-15.78
-18.71 -15.33 -14.88 -10.59
Income/Loss From Continuing Operations After Tax
15.68%
-15.78
-18.71 -15.33 -14.88 -10.59
Net Income/Loss
15.68%
-15.78
-18.71 -15.33 -14.88 -10.59
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.41%
58.75
58.50 58.25 0.3602 48.34
Diluted Average Shares
0.41%
58.75
58.50 58.25 0.3602 48.34
Basic Earnings Per Share
15.62%
-0.27
-0.32 -0.26 -0.30 -0.22
Diluted Earnings Per Share
15.62%
-0.27
-0.32 -0.26 -0.30 -0.22
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):